REPORT ID 833

Global Tuberculosis Drugs Market Size, Status and Forecast 2022

Publish Date
04-Dec-17
Pages
109
Format
Electronic (PDF)

This report studies the global Tuberculosis Drugs market, analyzes and researches the Tuberculosis Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    Sanofi
    Pfizer
    Janssen Products
    Otsuka
    AstraZeneca
    Lupin Pharmaceuticals
    Akorn
    STI Pharma
    Sandoz
    Labatec Pharma SA
    Archivel Farma
    BioMerieux
    Cepheid
    Epistem

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, the product can be split into
    First-line Anti-TB Drugs
    Second-line Anti-TB Drugs

Market segment by Application, Tuberculosis Drugs can be split into
    New Patients
    Drug Resistant TB Patients

If you have any special requirements, please let us know and we will offer you the report as you want.


 
			   
Table of Contents

Global Tuberculosis Drugs Market Size, Status and Forecast 2022
1 Industry Overview of Tuberculosis Drugs
    1.1  Tuberculosis Drugs Market Overview
        1.1.1 Tuberculosis Drugs Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Tuberculosis Drugs Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Tuberculosis Drugs Market by Type
        1.3.1 First-line Anti-TB Drugs
        1.3.2 Second-line Anti-TB Drugs
    1.4 Tuberculosis Drugs Market by End Users/Application
        1.4.1 New Patients
        1.4.2 Drug Resistant TB Patients

2 Global Tuberculosis Drugs Competition Analysis by Players
    2.1 Tuberculosis Drugs Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 Sanofi
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Tuberculosis Drugs Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 Pfizer
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Tuberculosis Drugs Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Janssen Products
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Tuberculosis Drugs Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Otsuka
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Tuberculosis Drugs Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 AstraZeneca
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Tuberculosis Drugs Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 Lupin Pharmaceuticals
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Tuberculosis Drugs Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 Akorn
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Tuberculosis Drugs Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 STI Pharma
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Tuberculosis Drugs Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 Sandoz
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Tuberculosis Drugs Revenue (Value) (2012-2017)
        3.9.5 Recent Developments
    3.10 Labatec Pharma SA
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Tuberculosis Drugs Revenue (Value) (2012-2017)
        3.10.5 Recent Developments
    3.11 Archivel Farma
    3.12 BioMerieux
    3.13 Cepheid
    3.14 Epistem

4 Global Tuberculosis Drugs Market Size by Type and Application (2012-2017)
    4.1 Global Tuberculosis Drugs Market Size by Type (2012-2017)
    4.2 Global Tuberculosis Drugs Market Size by Application (2012-2017)
    4.3 Potential Application of Tuberculosis Drugs in Future
    4.4 Top Consumer/End Users of Tuberculosis Drugs

5 United States Tuberculosis Drugs Development Status and Outlook
    5.1 United States Tuberculosis Drugs Market Size (2012-2017)
    5.2 United States Tuberculosis Drugs Market Size and Market Share by Players (2016 and 2017)

6 EU Tuberculosis Drugs Development Status and Outlook
    6.1 EU Tuberculosis Drugs Market Size (2012-2017)
    6.2 EU Tuberculosis Drugs Market Size and Market Share by Players (2016 and 2017)

7 Japan Tuberculosis Drugs Development Status and Outlook
    7.1 Japan Tuberculosis Drugs Market Size (2012-2017)
    7.2 Japan Tuberculosis Drugs Market Size and Market Share by Players (2016 and 2017)

8 China Tuberculosis Drugs Development Status and Outlook
    8.1 China Tuberculosis Drugs Market Size (2012-2017)
    8.2 China Tuberculosis Drugs Market Size and Market Share by Players (2016 and 2017)

9 India Tuberculosis Drugs Development Status and Outlook
    9.1 India Tuberculosis Drugs Market Size (2012-2017)
    9.2 India Tuberculosis Drugs Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Tuberculosis Drugs Development Status and Outlook
    10.1 Southeast Asia Tuberculosis Drugs Market Size (2012-2017)
    10.2 Southeast Asia Tuberculosis Drugs Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Tuberculosis Drugs Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Tuberculosis Drugs Revenue and Growth Rate (2017-2022)
        11.1.2 EU Tuberculosis Drugs Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Tuberculosis Drugs Revenue and Growth Rate (2017-2022)
        11.1.4 China Tuberculosis Drugs Revenue and Growth Rate (2017-2022)
        11.1.5 India Tuberculosis Drugs Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Tuberculosis Drugs Revenue and Growth Rate (2017-2022)
    11.2 Global Tuberculosis Drugs Market Size (Value) by Type (2017-2022)
    11.3 Global Tuberculosis Drugs Market Size by Application (2017-2022)

12 Tuberculosis Drugs Market Dynamics
    12.1 Tuberculosis Drugs Market Opportunities
    12.2 Tuberculosis Drugs Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Tuberculosis Drugs Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Tuberculosis Drugs Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source